{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:31:13Z","timestamp":1759365073499,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ajic.2004.03.007","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T11:08:38Z","timestamp":1096456118000},"page":"333-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of semipermeable dressings on smallpox vaccine site evolution"],"prefix":"10.1016","volume":"32","author":[{"given":"Jason A.","family":"Regules","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Hepburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Van De Car","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kepler A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane R.","family":"Hospenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clinton K.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Fofaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Ekstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen K.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2004.03.007_bib1","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2004.03.007_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/377236","article-title":"Transmission of vaccinia virus and rationale for measures for prevention","volume":"37","author":"Lane","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2004.03.007_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajic.2003.08.006","article-title":"The frequency of vaccinia virus isolation on semipermeable vs. non-occlusive dressings covering smallpox vaccination sites in hospital personnel","volume":"32","author":"Hepburn","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2004.03.007_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein","volume":"337","author":"Cooney","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2004.03.007_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/infdis\/166.2.244","article-title":"Vaccination of vaccinia-na\u00efve adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial","volume":"166","author":"Graham","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2004.03.007_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2004.03.007_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2004.03.007_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.288.15.1901","article-title":"Contact vaccinia-transmission of vaccinia from smallpox vaccination","volume":"288","author":"Neff","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2004.03.007_bib9","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1001\/jama.289.24.3306","article-title":"Smallpox immunization in the 21st century: the old and new","volume":"289","author":"Wright","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2004.03.007_bib10","unstructured":"Tegaderm product description. 3M skin health products: clinical conditions: IV site complications. Investigation of bacterial growth and moisture handling properties of transparent dressings. Available from: http:\/\/www.3m.com\/us\/healthcare\/professionals\/skinhealth\/jhtml\/iv_site_complications.jhtml. Accessed March 24, 2004."},{"key":"10.1016\/j.ajic.2004.03.007_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1086\/503496","article-title":"Semipermeable dressing used to cover smallpox vaccination sites as a cause of skin damage","volume":"25","author":"Crittenton","year":"2004","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655304004559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655304004559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:27:02Z","timestamp":1759296422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655304004559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0196655304004559"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2004.03.007","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of semipermeable dressings on smallpox vaccine site evolution","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2004.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}